Bucio-Ortiz L, Enriquez-Navarro K, Maldonado-Rodriguez A, Torres-Flores J, Cevallos A, Salcedo M
Pathogens. 2024; 13(8).
PMID: 39204261
PMC: 11357063.
DOI: 10.3390/pathogens13080662.
Saitta C, Pollicino T, Raimondo G
Viruses. 2022; 14(7).
PMID: 35891484
PMC: 9318873.
DOI: 10.3390/v14071504.
Luk K, Gersch J, Harris B, Holzmayer V, Mbanya D, Sauleda S
Sci Rep. 2021; 11(1):23838.
PMID: 34903774
PMC: 8668879.
DOI: 10.1038/s41598-021-03304-w.
Inoue J, Sato K, Ninomiya M, Masamune A
Viruses. 2021; 13(6).
PMID: 34208172
PMC: 8230773.
DOI: 10.3390/v13061124.
Pollicino T, Caminiti G
Viruses. 2021; 13(3).
PMID: 33652619
PMC: 7996909.
DOI: 10.3390/v13030368.
A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries.
Madihi S, Syed H, Lazar F, Zyad A, Benani A
Biomed Res Int. 2020; 2020:7027169.
PMID: 32626758
PMC: 7305551.
DOI: 10.1155/2020/7027169.
Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection.
Tian C, Dai J, Zhang W, Liu Y, Yang Y
Medicine (Baltimore). 2019; 98(23):e15924.
PMID: 31169710
PMC: 6571420.
DOI: 10.1097/MD.0000000000015924.
Naturally Occurring Hepatitis B Virus Mutations Leading to Endoplasmic Reticulum Stress and Their Contribution to the Progression of Hepatocellular Carcinoma.
Choi Y, Lee S, Kim B
Int J Mol Sci. 2019; 20(3).
PMID: 30704071
PMC: 6387469.
DOI: 10.3390/ijms20030597.
Up-regulation of brain-expressed X-linked 2 is critical for hepatitis B virus X protein-induced hepatocellular carcinoma development.
Huang F, Cai P, Wang Y, Zhou X, Chen H, Liao W
Oncotarget. 2017; 8(39):65789-65799.
PMID: 29029472
PMC: 5630372.
DOI: 10.18632/oncotarget.19477.
Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine.
Cai S, Cao J, Yu T, Xia M, Peng J
Medicine (Baltimore). 2017; 96(22):e7021.
PMID: 28562554
PMC: 5459719.
DOI: 10.1097/MD.0000000000007021.
Update on occult hepatitis B virus infection.
Makvandi M
World J Gastroenterol. 2016; 22(39):8720-8734.
PMID: 27818588
PMC: 5075547.
DOI: 10.3748/wjg.v22.i39.8720.
Optimal Follow-up of Patients with Viral Hepatitis Improves the Detection of Early-stage Hepatocellular Carcinoma and the Prognosis of Survival.
Oeda S, Iwane S, Takasaki M, Furukawa N, Otsuka T, Eguchi Y
Intern Med. 2016; 55(19):2749-2758.
PMID: 27725532
PMC: 5088533.
DOI: 10.2169/internalmedicine.55.6730.
Hepatitis B Virus-Related Hepatocellular Carcinoma: Pathogenic Mechanisms and Novel Therapeutic Interventions.
Xu H, Liu Y, Guleng B, Ren J
Gastrointest Tumors. 2015; 1(3):135-45.
PMID: 26676160
PMC: 4645579.
DOI: 10.1159/000365307.
Establishment of drug-resistant HBV small-animal models by hydrodynamic injection.
Cheng J, Han Y, Jiang J
Acta Pharm Sin B. 2015; 4(4):270-6.
PMID: 26579395
PMC: 4629082.
DOI: 10.1016/j.apsb.2014.06.009.
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.
Sarin S, Kumar M, Lau G, Abbas Z, Chan H, Chen C
Hepatol Int. 2015; 10(1):1-98.
PMID: 26563120
PMC: 4722087.
DOI: 10.1007/s12072-015-9675-4.
Mate-Pair Sequencing as a Powerful Clinical Tool for the Characterization of Cancers with a DNA Viral Etiology.
Gao G, Smith D
Viruses. 2015; 7(8):4507-28.
PMID: 26262638
PMC: 4576192.
DOI: 10.3390/v7082831.
Demethylation of tumor necrosis factor-α converting enzyme promoter associated with high hepatitis B e antigen level in chronic hepatitis B.
Wang Z, Gao S, Li X, Sun F, Li F, Fan Y
World J Gastroenterol. 2015; 21(27):8382-8.
PMID: 26217090
PMC: 4507108.
DOI: 10.3748/wjg.v21.i27.8382.
Androgen receptor in hepatocarcinogenesis: Recent developments and perspectives.
Tian Y, Xie X, Lin Y, Tan G, Zhong W
Oncol Lett. 2015; 9(5):1983-1988.
PMID: 26136999
PMC: 4467293.
DOI: 10.3892/ol.2015.3025.
Molecular mechanisms underlying HBsAg negativity in occult HBV infection.
Ponde R
Eur J Clin Microbiol Infect Dis. 2015; 34(9):1709-31.
PMID: 26105620
DOI: 10.1007/s10096-015-2422-x.
Hepatocellular carcinoma with concomitant hepatic angiomyolipoma and cavernous hemangioma in one patient.
Ge X, Zeng H, Su-Jie A, Du M, Ji Y, Tan Y
World J Gastroenterol. 2015; 21(11):3414-9.
PMID: 25805953
PMC: 4363776.
DOI: 10.3748/wjg.v21.i11.3414.
